View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Functional and biomarker assays for the exploration of every angle of the complement system
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Let us develop a custom iLite® cell line tailored to your needs.
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
Scientific poster title: "iLite® cell-based assays – A good fit to evaluate the most critical parameters included in the clinical bioassay characterization iLite hCG case study"
In this scientific poster, we showcase that iLite hCG Assay Ready Cells can be used for the quantification of hCG activity, or neutralizing antibody response against hCG in test samples, including human serum.
Ferring has used iLite cells and their proprietary drug/API to develop bioanalytical assays determining the most critical parameters monitored during drug development:
• Serum tolerance
• Cut-point determination
• NAb assay sensitivity
• Drug tolerance at high level of drug
The iLite technology can be adapted for many applications throughout the drug development phases including drug manufacturing processes such as the quantification of vector potency and functionality or the detection of neutralizing anti-drug antibodies (NAb).